carbostyril has been researched along with Sexually Transmitted Diseases, Bacterial in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G; Winkler, I | 1 |
| Segreti, J | 2 |
| Pankey, GA | 1 |
| Hardy, DJ | 1 |
1 review(s) available for carbostyril and Sexually Transmitted Diseases, Bacterial
| Article | Year |
|---|---|
Temafloxacin: an overview.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Prostatitis; Quinolones; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Infectious; Urinary Tract Infections | 1991 |
4 other study(ies) available for carbostyril and Sexually Transmitted Diseases, Bacterial
| Article | Year |
|---|---|
Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases.
Topics: Cefpirome; Cephalosporins; Chancroid; Chlamydia; Chlamydia Infections; Gardnerella vaginalis; Gonorrhea; Haemophilus ducreyi; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quinolones; Sexually Transmitted Diseases, Bacterial | 1992 |
Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis.
Topics: Anti-Infective Agents; Female; Fluoroquinolones; Gonorrhea; Humans; Male; Quinolones; Sexually Transmitted Diseases, Bacterial; Urethritis; Uterine Cervicitis | 1991 |
In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Topics: Anti-Infective Agents; Campylobacter; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial | 1991 |
In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma; Neisseria gonorrhoeae; Quinolones; Sexually Transmitted Diseases, Bacterial; Treponema pallidum; Ureaplasma urealyticum | 1991 |